- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04928339
Pecto-Intercostal Fascial Plane Block Study
Pecto-Intercostal Fascial Plane Block for Enhanced Recovery After Cardiac Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Thousands of heart surgeries are performed every day in the United States. Unattenuated perioperative pain has been shown to contribute to increased morbidity, mortality, length of stay, and healthcare costs. Practice guidelines from the American Society of Regional Anesthesiologists recommend pre-incision techniques to reduce perioperative pain, however in cardiac surgery, there are no commonly used techniques to follow this recommendation. The PIFB is a newly described fascial plane block and existing literature supports the safety and efficacy of the PIFB in cardiac surgery patients. However, there are no randomized controlled trials evaluating this technique with a long-acting depot local anesthetic.
The purpose of this study is to determine whether bilateral pecto-intercostal fascial plane blocks with liposomal bupivacaine decrease pain and opioid requirements in patients undergoing cardiac surgery via median sternotomy compared to controls (sham blocks with saline). The primary hypothesis is that patients receiving effective regional anesthesia with liposomal bupivacaine via PIFB will demonstrate a clinically significant (25%) reduction in total daily opioid consumption through 72 hours postoperatively compared to patients receiving standard of care without effective regional anesthesia (saline only via PIFB).
This study is a prospective, single-center, randomized, double-blind, controlled trial to evaluate whether bilateral pecto-intercostal fascial plane blocks with liposomal and standard bupivacaine decrease pain and opioid requirements in patients undergoing cardiac surgery via median sternotomy compared to controls (sham blocks with saline).
The participants will be randomized to receive bilateral PIFB with a mixture of standard and liposomal bupivacaine or bilateral PIFB with saline only. Recovery characteristics, including opioid consumption, pain scores, duration of mechanical ventilation, ICU length of stay, hospital length of stay, side effects, and chronic opioid use will be evaluated.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Helen Akere
- Phone Number: (608) 265-3243
- Email: akere@wisc.edu
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin Hospital and Clinics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participant provides consent to participate in study
- Ideal body weight (IBW) is >50kg
- Participant is planned to undergo coronary artery bypass graft or single valve repair/replacement surgery via median sternotomy
- Participant is undergoing an elective procedure
Exclusion Criteria:
- Participant is unable or unwilling to give consent
- Non-English speaking
- Known or believed to be pregnant or is currently breastfeeding
- Participant is a prisoner
- Clinically unstable per discretion of the Investigator
- Participant requires urgent/emergent surgery
- History of previous sternotomy
- Preoperative coagulopathy (INR >1.4, platelets <100,000) or ongoing anticoagulation or anti-platelet therapy (except aspirin 81mg)
- Allergy or sensitivity to amide-type local anesthetics, dexmedetomidine or ketamine
- Participant has decompensated heart failure
- Severe left ventricle dysfunction (defined quantitatively as an ejection fraction of less than or equal to 35%) or right ventricle dysfunction (defined qualitatively as "severe")
- Diagnosis of cirrhosis or end-stage liver disease
- Requires the use of mechanical circulatory support pre-operatively
- Participant uses chronic opioids (meaning at the time of the preoperative screening evaluation by the study team, the patient is prescribed and taking any opioid pain medication)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PIFB intervention
bilateral PIFB with a mixture of standard 0.25% bupivacaine (15 mL) and 133 mg liposomal bupivacaine (10mL)
|
10mL of 0.25% bupivacaine
15mL of 133mg liposomal bupivacaine
|
Sham Comparator: Saline Control
bilateral PIFB with 25 mL saline only
|
25mL saline control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Opioid Consumption 72 hours postoperatively
Time Frame: up to 72 hours post-op
|
Total opioid consumption during the initial 72 hours postoperatively will be measured in morphine equivalents and compared between groups.
|
up to 72 hours post-op
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Intraoperative Opioid Consumption
Time Frame: intraoperative
|
Total intraoperative opioid consumption will be measured in morphine equivalents and compared between groups.
|
intraoperative
|
Daily Mean Pain Scores first 72 hours Postoperatively
Time Frame: up to 72 hours post-op
|
Pain will be assessed, according to standard of care, every 4 hours using the 11-point Numerical Rating Scale (NRS), beginning at time 0 (arrival to ICU).
Each patient's pain scores (higher scores indicate worse pain) within each postoperative day will be averaged, and the mean pain scores during each day and throughout the first 72 hours will be compared between the intervention and control groups.
|
up to 72 hours post-op
|
Maximum Pain Scores up to 72 hours Postoperatively
Time Frame: up to 72 hours post-op
|
Pain will be assessed, according to standard of care, every 4 hours using the 11-point Numerical Rating Scale (NRS) where higher score indicate worse pain, beginning at time 0 (arrival to ICU).
Maximum pain scores will be compared between groups.
|
up to 72 hours post-op
|
Pain Score at 90 days Postoperatively
Time Frame: up to 90 days post-op
|
Pain will be assessed, according to standard of care, every 4 hours using the 11-point Numerical Rating Scale (NRS) where higher score indicate worse pain.
Pain at 90 days postoperative will be surveyed by phone.
|
up to 90 days post-op
|
Daily Opioid Consumption up to 72 hours Postoperatively
Time Frame: up to 72 hours post-op
|
Daily opioid consumption during the initial 72 hours postoperatively will be measured in morphine equivalents and compared between groups.
|
up to 72 hours post-op
|
Hours of Mechanical Ventilation after ICU admission
Time Frame: up to 72 hours post-op
|
Duration of mechanical ventilation will be measured by hours of mechanical ventilation after admission to the ICU.
|
up to 72 hours post-op
|
Number of postoperative days until the first Bowel Movement
Time Frame: up to 72 hours post-op
|
Return of bowel function will be measured in the number of postoperative days until the first bowel movement.
|
up to 72 hours post-op
|
Incidence of Postoperative Delirium per the Confusion Assessment Method for the ICU (CAM-ICU)
Time Frame: up to 72 hours post-op
|
Postoperative delirium will be measured according to standard of care by utilizing the CAM-ICU assessment every 8-12 hours.
The CAM-ICU determines either 'yes' or 'no' the participant is experiencing delirium.
|
up to 72 hours post-op
|
Number of Hours that the Patient is in the ICU
Time Frame: up to 72 hours post-op
|
Duration of ICU stay will be measured by the number of hours that the patient is in the ICU until an order is placed for transfer to a lower level of care.
|
up to 72 hours post-op
|
Number of post-operative days until the Patient is Discharged
Time Frame: up to 7 days
|
Duration of hospital stay will be measured by the number of post-operative days until the patient is discharged.
|
up to 7 days
|
Number of Participants Using Opioids at 90 days Postoperatively
Time Frame: up to 90 days post-op
|
Patient use of opioids at 90 days will be obtained by phone call.
|
up to 90 days post-op
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Patrick Meyer, MD, University of Wisconsin, Madison
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-0111
- Protocol Version 3/13/2021 (Other Identifier: UW Madison)
- A530900 (Other Identifier: UW Madison)
- SMPH/ANESTHESIOLOGY (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Surgery
-
Nationwide Children's HospitalCompleted
-
Universitätsklinikum Hamburg-EppendorfRecruitingSerratus Anterior Plane Block | Minimal Invasive Cardiac Surgery | Minimal Invasive Cardiac Surgery Mitral Valve SurgeryGermany
-
Shanghai Zhongshan HospitalRecruitingCardiac Surgery | Cardiac OutputChina
-
Sheba Medical CenterTerminatedDisorder; Heart, Functional, Postoperative, Cardiac Surgery | Heart; Dysfunction Postoperative, Cardiac SurgeryIsrael
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Population Health Research Institute and other collaboratorsActive, not recruitingSurgery (Cardiac) | Surgery (Major Vascular)Canada, United Kingdom
-
Maquet Cardiopulmonary GmbHNAMSARecruitingCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain
-
Baylor Research InstituteChiesi USA, Inc.RecruitingSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Yan FuxiaNot yet recruitingCardiac Surgery | Enhanced Recovery After SurgeryChina
-
Yonsei UniversityCompletedCardiac Surgery | Vascular Surgery Using CPBKorea, Republic of
Clinical Trials on Bupivacaine Injection
-
Broward HealthCompleted
-
University of South FloridaCompletedPain, Postoperative | Carpal Tunnel SyndromeUnited States
-
University of Texas Southwestern Medical CenterCompleted
-
Istanbul UniversityCompletedPain, PostoperativeTurkey
-
The University of Texas Health Science Center at...Recruiting
-
Peking University First HospitalRecruitingAnalgesia | Paravertebral Block | Regional Block | Local AnestheticsChina
-
Istanbul UniversityCompletedPain, PostoperativeTurkey
-
University of California, San FranciscoCompletedPostoperative Pain | Thoracic Diseases | Opioid UseUnited States
-
Wake Forest University Health SciencesRecruitingMorbid Obesity | Bariatric Surgery CandidateUnited States
-
The University of Hong KongNot yet recruiting